Indications and dosage of Lenvatinib
                     Indication
s and 
Dosage of 
Lenvatini
b
Indication:
• Lenvatinib, an anticancer medication recommended for 
use in order to treat patients with the locally recurrent 
or metastatic, progressive, radioactive iodine-refractory 
differentiated thyroid cancer (DTC).
• It is used together with the everolimus for treating 
patients with advanced renal cell carcinoma (RCC) 
following one prior vascular endothelial growth factor 
(VEGF)-targeted therapy.
• It is also recommended as the first-line treatment for 
adult patients with unresectable hepatocellular 
carcinoma (HCC). 
Dosage of Lenvatinib: 
Dose for Differentiated Thyroid Cancer (DTC): The recommended usual 
dose of Lenvatinib is 24 mg, should be consumed orally once daily until the 
disease progression or until the unacceptable toxicity.
Dose for Renal Cell Carcinoma (RCC): The recommended usual dose of 
Lenvatinib is 18 mg together with the 5 mg everolimus, should be consumed 
orally once daily until the disease progression or until the unacceptable toxicity. 
Refer to the everolimus prescribing information for recommended dosing 
information about everolimus. 
Dose for Hepatocellular Carcinoma (HCC): The recommended usual dose of 
Lenvatinib is based on the actual body weight: 
Lenvatinib 12 mg for the patients who are greater than or equal to 60 kg or 
Lenvatinib 8 mg for the patients who are less than 60 kg. 
Pricing & Availability
• Lenvatinib price in India is economical due to multiple 
generic brands are there, the only thing you need to 
keep in mind that you are choosing a legitimate 
pharmaceutical wholesaler while purchasing. 
• It is easily available at The Indian Pharma. Indian 
Pharma can offer different generic brands of Lenvatinib 
to the patients.